# Radiofrequency Endometrial Ablation or Uterine Artery Embolization for Treatment of Adenomyosis-related Abnormal Uterine Bleeding

> **NCT07195305** · NA · RECRUITING · sponsor: **University Hospital, Bordeaux** · enrollment: 230 (estimated)

## Conditions studied

- Abnormal Uterine Bleeding Due to Adenomyosis (Disorder)

## Interventions

- **PROCEDURE:** Radiofrequency endometrial ablation
- **PROCEDURE:** Uterine artery embolization
- **PROCEDURE:** Hysterectomy

## Key facts

- **NCT ID:** NCT07195305
- **Lead sponsor:** University Hospital, Bordeaux
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-04-17
- **Primary completion:** 2029-05
- **Final completion:** 2029-05
- **Target enrollment:** 230 (ESTIMATED)
- **Last updated:** 2026-04-20

## Collaborators

- French Ministry of Social Affairs and Health

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07195305

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07195305, "Radiofrequency Endometrial Ablation or Uterine Artery Embolization for Treatment of Adenomyosis-related Abnormal Uterine Bleeding". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT07195305. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*